| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $751.5M | +17.8% |
| Cost of Revenue | $231.6M | +9.9% |
| Gross Profit | $519.9M | +21.7% |
| R&D Expense | $68.7M | +9.3% |
| SG&A Expense | $126.6M | +23.0% |
| Operating Income | $118.3M | +33.1% |
| Pre-tax Income | $123.8M | +24.5% |
| Income Tax | $30.5M | +36.0% |
| Net Income | $93.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.4M | -37.2% |
| Accounts Receivable | $68.2M | +31.0% |
| Current Assets | $335.3M | -12.2% |
| Total Assets | $1.17B | +13.4% |
| Current Liabilities | $154.4M | +5.2% |
| Total Liabilities | $196.0M | +11.0% |
| Stockholders' Equity | $973.9M | +13.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $178.8M | +13.6% |
| Capital Expenditures | $26.5M | +32.3% |
| Investing Cash Flow | -$169.2M | -53.1% |
| Financing Cash Flow | -$100.8M | -337.9% |
| Free Cash Flow | $152.3M | +10.9% |
| +21.1% |
| EPS (Basic) | $2.46 | +18.8% |
| EPS (Diluted) | $2.46 | +20.6% |